Frovatriptan Tablet, Film Coated
Product Images NDC 50742-299

7 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Frovatriptan (NDC 50742-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (0ab7825b C92c 45e2 Abaa Cb115564b312 01)

Image 1 (0ab7825b C92c 45e2 Abaa Cb115564b312 01)
Chemical structure of frovatriptan succinate, the active ingredient in FROVATRIPTAN 2.5 mg film-coated tablets by Ingenus Pharmaceuticals, LLC. The diagram depicts the molecular arrangement including an indole core and succinate moiety with a water molecule.*
FDA Label Image

Image 2 (0ab7825b C92c 45e2 Abaa Cb115564b312 02)

Image 2 (0ab7825b C92c 45e2 Abaa Cb115564b312 02)
A Kaplan-Meier plot showing the estimated probability of response over time from the initial dose in hours, comparing Placebo (dashed line) and Frovatriptan Succinate Tablets 2.5 mg (solid line). The graph illustrates higher response probability with Frovatriptan Succinate Tablets up to 2 hours post-dose.*
FDA Label Image

Image 3 (0ab7825b C92c 45e2 Abaa Cb115564b312 03)

Image 3 (0ab7825b C92c 45e2 Abaa Cb115564b312 03)
A line graph comparing the estimated probability of remediation or rescue over 24 hours following the initial dose of Frovatriptan Succinate Tablets 2.5 mg versus placebo. The x-axis represents time from the initial dose in hours (0 to 24), and the y-axis shows the estimated probability in percentage (0% to 100%). Two lines depict the response: a solid line for Frovatriptan Succinate Tablets 2.5 mg and a dashed line for placebo.*
FDA Label Image

Image 4 (0ab7825b C92c 45e2 Abaa Cb115564b312 04)

FDA Label Image

Image (0ab7825b C92c 45e2 Abaa Cb115564b312 113 2)

FDA Label Image

Blister Label (Frovatriptan Blister)

Blister Label (Frovatriptan Blister)
Blister packaging label for Frovatriptan Succinate tablets, each containing 2.5 mg (base) of the active ingredient. The medication is manufactured for Ingenus Pharmaceuticals, intended for prescription use only (Rx Only). The label includes space for lot number and expiration date, as well as barcodes and an unwinding direction indicator for the foil seal.*
FDA Label Image

Carton Label (Frovatriptan Carton)

Carton Label (Frovatriptan Carton)
Frovatriptan Succinate Tablets 2.5 mg film-coated tablet packaging label by Ingenus Pharmaceuticals, LLC. The label indicates a blister card containing 9 tablets with the NDC 50742-299-09. The label includes storage instructions, manufacturing details, and images of tablets marked with "ZNF" and "2.5." The packaging is white with black text and blue Ingenus logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.